You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 23, December 17, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Conflict of Interest
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Als-Nielsen and colleagues1 concluded that trials funded by for-profit organizations are more likely to have positive conclusions due to biased interpretation of trial results. Although Als-Nielsen et al found that trials funded by for-profit organizations more often demonstrate increased differences compared with control groups, they found that such trials are more likely to use placebos as a control, report a higher frequency of adverse effects, reach preplanned numbers of subjects, and be published in high-impact journals.

These results imply that for-profit organizations seem to plan and execute studies more rigorously than do nonprofit organizations. As a consequence, it seems that conclusions drawn from studies run by for-profit organizations are more trustworthy. This could be explained by the extensive guideline system governing for-profit organization trials, including the International Conference on Harmonisation (ICH) Good Clinical Practice guidelines2 and others. Studies performed by for-profit organizations are very often used . . . [Full Text of this Article]

Stig Waldorff, MD
Clinical Research Committee
The Danish Association of the Pharmaceutical Industry
Copenhagen, Denmark



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities
Robert H. Palmer
JAMA. 2003;290(23):3070.
EXTRACT | FULL TEXT  

Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities
Jonathan B. Rosefsky
JAMA. 2003;290(23):3070-3071.
EXTRACT | FULL TEXT  

Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities—Reply
Bodil Als-Nielsen, Wendong Chen, Christian Gluud, and Lise Lotte Kjaergard
JAMA. 2003;290(23):3071-3072.
EXTRACT | FULL TEXT  

Association of Funding and Conclusions in Randomized Drug Trials: A Reflection of Treatment Effect or Adverse Events?
Bodil Als-Nielsen, Wendong Chen, Christian Gluud, and Lise L. Kjaergard
JAMA. 2003;290(7):921-928.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.